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ABSTRACT
Eukaryotic RNase H2 is a heterotrimeric enzyme.
Here, we show that the biochemical composition
and stoichiometry of the human RNase H2 complex
is consistent with the properties previously deduced
from genetic studies. The catalytic subunit of eukar-
yotic RNase H2, RNASEH2A, is well conserved and
similar to the monomeric prokaryotic RNase HII. In
contrast, the RNASEH2B and RNASEH2C subunits
from human and Saccharomyces cerevisiae share
very little homology, although they both form solu-
ble B/C complexes that may serve as a nucleation
site for the addition of RNASEH2A to form an active
RNase H2, or for interactions with other proteins
to support different functions. The RNASEH2B sub-
unit has a PIP-box and confers PCNA binding to
human RNase H2. Unlike Escherichia coli RNase
HII, eukaryotic RNase H2 acts processively and
hydrolyzes a variety of RNA/DNA hybrids with simi-
lar efficiencies, suggesting multiple cellular sub-
strates. Moreover, of five analyzed mutations in
human RNASEH2B and RNASEH2C linked to
Aicardi-Goutie `res Syndrome (AGS), only one, R69W
in the RNASEH2C protein, exhibits a significant
reduction in specific activity, revealing a role for
the C subunit in enzymatic activity. Near-normal
activity of four AGS-related mutant enzymes was
unexpected in light of their predicted impairment
causing the AGS phenotype.
INTRODUCTION
Formation and resolution of RNA/DNA hybrids created
during DNA replication and repair is central to the main-
tenance of genome stability. RNases H are the only known
enzymes that degrade the RNA strand of RNA/DNA
hybrids in a sequence nonspeciﬁc manner, and therefore,
are essential for DNA integrity (1). There are two types of
RNases H in eukaryotes that diﬀer by sequence, biochem-
ical properties and substrate speciﬁcity: (i) RNase H1,
which is homologous to prokaryotic RNase HI and the
RNase H domain of retroviral reverse transcriptase (1);
and (ii) RNase H2, which is a monomeric enzyme in pro-
karyotes, and is composed of three diﬀerent proteins in
eukaryotes (1). In Saccharomyces cerevisiae the RNase H2
heterotrimeric complex contains the catalytic subunit,
similar to prokaryotic RNase HII and two other subunits
that have no prokaryotic counterparts and whose func-
tions remain unknown (2).
Crow et al. (3) deﬁned the composition of the hetero-
trimeric human RNase H2 complex when they identiﬁed
pathogenic mutations in the three gene orthologs of
S. cerevisiae RNase H2 (Sc-RNase H2) subunits as
being causative of Aicardi-Goutie ` res Syndrome (AGS).
AGS is a genetic neurological disorder with symptoms
similar to those of congenital viral infection (3,4). It is
characterized by loss of brain white matter, intracranial
calciﬁcations, high levels of the cytokine interferon-a in
the cerebrospinal ﬂuid and elevated number of white
cells, suggesting activation of both the innate and adaptive
immune responses (3). Mutations in the gene encoding the
30-exonuclease TREX1 have also been found in AGS
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cer of AGS (5). In fact, TREX1-deﬁcient cells accumu-
lated single-stranded DNA molecules about 60nt long,
which induced chronic activation of the DNA damage
response-signaling network (6,7).
Most of AGS-related mutations in TREX1 have been
shown to abrogate its 30 to 50 exonuclease activity (5),
although heterozygosity for certain mutations can result
in other autosomal dominant disorders, such as chilblain
lupus (8). A C-terminal truncation that results in mis-
localization of TREX1, without aﬀecting its enzymatic
activity, is the cause of retinal vasculopathy and cerebral
leukodystrophy (RVCL), an autosomal-dominant degen-
erative disorder (9).
Unlike for TREX1, very little is known about human
RNase H2 alterations and no other disorders have been
associated with defects in RNase H2. All of the AGS-
related mutations found in the three subunits of RNase
H2 are missense mutations (4), perhaps an indication
that they are essential genes. One mutation found in
RNASEH2A (G37S) has been described to decrease sig-
niﬁcantly the RNase H2 activity of the complex (3).
However, the eﬀect of other mutations in RNASEH2B
and RNASEH2C subunits remains to be examined. A
larger number of AGS-related mutations have been
found in RNASEH2B than in other proteins. These muta-
tions usually have a later onset and decreased phenotypic
severity than mutations in other subunits (4). Because the
roles of the B and C subunits are not known, it is diﬃcult
to assess the defects associated with mutations in the genes
for these two proteins. Studying the functions of the
RNase H2 B/C subunits and their interactions with the
A subunit and other proteins would aid our understanding
of how the heterotrimeric RNase H2 complex works, and
how AGS is induced.
In addition to a structural role in supporting the activity
of the RNASEH2A catalytic subunit, the RNASEH2B
and RNASEH2C proteins may be involved in interactions
with other proteins. Genetic interactions have been
reported for all three genes encoding RNase H2 and
SGS1 (10,11), RAD27 (12,13) and ESC2 (14,15) in yeast.
SGS1p is a DNA helicase, RAD27p is the S. cerevisiae
Fen1 protein involved in removal of RNA primers and
ESC2p aﬀects recombination frequencies. These studies
suggest a function for RNase H2 in Okazaki fragment
processing during chromosomal DNA replication/repair,
although its exact role has not yet been determined.
Chromosomal DNA replication in eukaryotes is orche-
strated by the proliferating cell nuclear antigen (PCNA),
a protein responsible for bringing to the replication fork
and coordinating the activities of the elongating polymer-
ase and other factors involved in Okazaki fragment
processing (16). Most proteins that interact with PCNA
share a sequence, which physically contacts PCNA (17).
Recently, such a sequence has been reported in an
archaeal RNase HII, and the interaction with PCNA
was described as negatively aﬀecting the enzymatic activ-
ity of RNase HII (18).
In this study we determine PCNA interaction and other
contributions of the two accessory subunits, RNASEH2B
and RNASEH2C, to the activity and properties of the
human RNase H2 complex, and examine the eﬀect of
several AGS-related mutations, particularly those present
in the B and C subunits of RNase H2.
MATERIALS AND METHODS
HeLacells expression system and immunopurification
HeLa-XZ cells can grow both in a suspension and in an
adherent state. The cell line was cultured in high glucose
Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum, nonessential
amino acids, 100U/ml penicillin, 100mg/ml streptomycin
(Invitrogen) with 5% CO2 at 378C.
Human RNASEH2A gene was cloned into XhoI/NotI
site of pOPAV (19), an MMLV-derived retrovirus vector,
which results in fusion of FLAG- and HA-epitopes
(MDYKDDDDKLDGGYPYDVPDYAGGLE, FLAG
and HA epitopes are underlined, respectively) at the N-
terminus of human RNASEH2A. Establishment of stable
HeLa cell line expressing the FLAG-HA-tagged human
RNASEH2A (HeLa RNASEH2A cell line) was carried
out as described previously (19).
Puriﬁcation of RNase H2 from HeLa RNASEH2A cell
was performed as follows: Cells (10
7) were cultured to
90% conﬂuence and then extracted for 1h with 500ml
lysis buﬀer [20mM Tris–HCl at pH 7.9, 100mM KCl,
5mM MgCl2, 10% glycerol, 0.1% NP-40 and Protease
inhibitor cocktail Set III EDTA-free (Calbiochem)]. The
extract was incubated with 10ml M2 anti-FLAG agarose
(Sigma) for 2h with rotation (Nutator). Beads were
washed in the lysis buﬀer. Bound proteins were eluted
by incubation for 1h with 200ml of lysis buﬀer containing
0.2mg/ml FLAG peptide (Sigma) with rotation.
Large-scale puriﬁcation of RNase H2 from HeLa cells
and identiﬁcation of interacting proteins with mass spec-
trometry was carried out as described previously (19).
Construction ofplasmid for expression ofhuman
RNase H2 inEscherichia coli
To construct pET-hH2A, pET-hH2B and pET-hH2C,
the DNA fragments that contain RNASEH2A,
RNASEH2B and RNASEH2C were ampliﬁed from
cDNAs and cloned into NdeI/XhoI site of pET15b. For
coexpression of RNASEH2A and RNASEH2C, pET-
hH2AC was constructed as follows: RNASEH2C cDNA
fragment which is ﬂanked by EcoRI (30-side) and blunt-
ended XbaI (50-side) was prepared from pET-hH2C and
ligated into EcoRI/blunt-ended XhoI site of pET-hH2A,
which resulted in insertion of ribosomal binding site and
RNASEH2C ORF at the 30-side of RNASEH2A gene, so
that expression of both RNASEH2A and RNASEH2C is
under the control of single T7 promoter in pET-hH2AC.
This strategy was also applied for construction of other
combinations of polycistronic coexpression systems. To
construct pET-hH2AB, RNASEH2B ORF fragment was
inserted into 30-side of RNASEH2A gene in pET-hH2A.
Likewise, the three subunits coexpression plasmid, pET-
hH2ABC, was constructed by inserting RNASEH2B
ORF fragment into pET-hH2AC at the 30-side of
RNASEH2C gene. The plasmid, pET-hH2BC2, from
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scribed separately from diﬀerent T7 promoters, was con-
structed as follows: RNASEH2B ORF fragment which is
ﬂanked by EcoRI (30-side) and blunt-ended BglII (50-side)
was prepared from pET-hH2B and ligated into EcoRI/
blunt-ended HindIII site of pET-hH2C. For mutational
studies, the QuikChange IIXL kit (Stratagene) was used
to generate all site-directed mutations and deletions, and
changes were conﬁrmed by DNA sequence determination.
Complementation assay
Escherichia coli strain MIC1066 [rnhA339::cat,
recB270(Ts)] (20) was transformed with plasmids con-
taining series of combinations of RNase H2 subunits;
pET-hH2A, pET-hH2B, pET-hH2C, pET-hH2AC,
pET-hH2AB, pET-hH2BC2, pET-hH2ABC. The transfor-
mants were streaked on LB-ampicillin plates, and the abil-
ity of colony formation at 32 and 428C was examined.
Escherichia coli expression and purification of human
RNase H2
For expression of human RNase H2, E. coli MIC1066 was
transformed with pET-hH2ABC and cultured at 328C
overnight in MagicMedia
TM (Invitrogen). Cells were har-
vested by centrifugation at 6000g for 10min, suspended in
20mM Tris–HCl pH 7.5 containing 0.5M NaCl and
30mM imidazole (buﬀer A), disrupted by sonication and
centrifuged at 30000g for 30min. The supernatant was
loaded onto a Histrap FF crude column (1ml) (GE
Healthcare) equilibrated with buﬀer A. The protein was
eluted from the column with a step gradient of 30, 100,
300, 500mM imidazole. The protein eluted at 300mM imi-
dazole was diluted by addition of 9 volumes of 20mM
Tris–HCl pH 7.5 containing 1mM EDTA (TE buﬀer)
and applied to Hitrap Heparin HP (GE Healthcare) equi-
librated with TE buﬀer. The protein was eluted from the
column with a step gradient of 0.1, 0.3, 0.5, 1.0, 1.5M
NaCl. The protein eluted at 1M NaCl was dialyzed against
20mM Tris–HCl pH 7.5 containing 1mM EDTA and
150mM NaCl and concentrated. The purity of the protein
was conﬁrmed by SDS–PAGE, followed by staining with
Coomassie brilliant blue R250 (CBB). Expression and pur-
iﬁcation of human RNase H2 mutants were carried out as
described for wild-type protein. For coexpression of
RNASEH2B and RNASEH2C, E. coli MIC1066 was
transformed with pET-hH2BC2 and cultured overnight
in MagicMedia
TM (Invitrogen) at 328C. Two-step puri-
ﬁcation with Histrap crude FF 1ml column (GE Health-
care) and Hitrap Heparin HP 1ml column (GE
Healthcare) was performed according to the methods
described for human RNase H2A/B/C complex. Protein
concentrations were determined by measuring the absor-
bance at A280 of a 0.1% solution; 0.88 for human RNase
H2 wild-type and AGS-related mutants (a-G37S,
b-K162T, b-A177T, b-V185G and c-K143I mutants);
0.94 for c-R69W AGS-related mutant; 0.69 for RNA-
SEH2B/C complex. These values were calculated by
"=1576M
–1 for Tyr and 5225M
–1 for Trp at A280, assum-
ing that RNase H2A/B/C and B/C complexes have 1:1:1
and 1:1 subunit compositions, respectively (21).
Expression andpurification ofE. coli RNase HII
The plasmid, pET-hisEcH2, for expression of N-termin-
ally His-tagged E. coli RNase HII was recloned into
pET15b from a plasmid provided by M. Itaya, Keio
University. For production of E. coli RNase HII, E. coli
MIC1066 was transformed with pET-hisEcH2 and grown
in LB-media at 328C. When the absorbance at 600nm
reached around 0.5, 1mM isopropyl b-D-thiogalactopyr-
anoside (IPTG) was added to the culture medium and
cultivation was continued for an additional 3h. Two-
step puriﬁcation with Histrap crude FF 1ml column
(GE Healthcare) and Hitrap Heparin HP 1ml column
(GE Healthcare) was carried out as described for human
RNase H2 puriﬁcation. The puriﬁed protein was further
applied to a gel ﬁltration column (20 900mm) packed
with Sephacryl S-200 equilibrated with 40mM Tris–HCl
pH 7.5 containing 1mM EDTA and 150mM NaCl.
Fractions containing the protein were collected and used
for further analyses. The protein concentration was deter-
mined from the UV absorption using the A280 value of
0.55 for 0.1% solution, which was calculated as described
for human RNase H2.
Expression andpurification ofhuman PCNA
The plasmid, pAVR38 (22), for production of His-tagged
human PCNA was a gift from R. Woodgate, NICHD/
NIH. Escherichia coli MIC1066 was transformed with
pAVR38 and cultured overnight in MagicMedia
TM
(Invitrogen) at 328C. Puriﬁcation with Histrap crude FF
1ml column (GE Healthcare) was carried out as described
for human RNase H2 puriﬁcation. The fraction eluted
from Histrap crude FF was further puriﬁed with a gel
ﬁltration column as described in the methods for E. coli
RNase HII puriﬁcation. Fractions containing the protein
were collected and used for further analyses. The protein
concentration was determined from the UV absorption
using the A280 value of 0.52 for 0.1% solution, which
was calculated as described for human RNase H2.
RNase Hsubstrates
Poly-rA/poly-dT with uniformly
32P-labeled poly-rA
was prepared as described previously (23). Sequences of
short substrates are given in Supplementary Table S1.
50 32P-labeled RNA20/DNA20, DNA12–RNA1–DNA27/
DNA40 and DNA39–RNA1–DNA40/DNA80 hybrids
were prepared by hybridizing 50-
32P-labeled RNA20,
DNA12–RNA1–DNA27 and DNA39–RNA1–DNA40 with
1.5mole equivalent of their complementary DNA.
Gel renaturation assay
Extractions of HeLa cell lines and FLAG-tag puriﬁcation
were performed as described in methods for HeLa cells
expression system and immunopuriﬁcation. Renaturation
gel assays were performed with HeLa cell extracts and
FLAG-tag puriﬁed fraction from the HeLa cell lines as
described previously (24). The samples were applied to
15% SDS–PAGE containing poly-rA/poly-dT with uni-
formly
32P-labeled poly-rA, and after electrophoresis, the
gel was incubated overnight in 50mM Tris–HCl pH 7.9
98 Nucleic Acids Research, 2009, Vol. 37,No. 1containing 10mM MgCl2, 50mM NaCl and 10mM
2-mercaptoethanol at room temperature to remove the
SDS and allow the protein to renature and act on the
substrate. Autoradiograms were developed following
exposure of the gels to ﬁlms.
Specific RNase H activity
The speciﬁc RNase H activities of proteins were deter-
mined using 50 32P-labeled DNA12-RNA1-DNA27/DNA40
hybrid and poly-rA/poly-dT with uniformly
32P-labeled
poly-rA. Enzymes were diluted in 20mM Tris–HCl pH
7.5, 10% glycerol, 0.1mg/ml BSA. Hydrolysis of the sub-
strates was performed at 378C for 15min in 50mM Tris–
HCl pH 8.5 containing 50mM NaCl, 5mM MgCl2,1m M
2-mercaptoethanol, 50mg/ml BSA, 1% glycerol. Products
of 1mMo f
32P-labeled DNA12–RNA1–DNA27/DNA40
hydrolysis were applied to a 20% TBE-urea polyacryla-
mide gel. The reaction products were quantiﬁed by phos-
phorimaging. With the poly-rA/poly-dT substrate, RNase
H activity was determined by measuring the amount of
radioactivity of the acid-soluble digestion product from
the substrate (1mM) as described previously (24).
Processivity assaywithpoly-rA/poly-dT
Analysis of processivity with poly-rA/poly-dT was carried
out as described previously (25). One micromolar poly-rA/
poly-dT was digested with proteins, and products of the
hydrolysis were resolved on 12% TBE-urea PAGE gel.
Final products were deﬁned as oligonucleotides 12nt or
shorter in length, and intermediate products ranged from
13 to 100nt in lanes where <85% of the starting substrate
was degraded. Processivity was calculated by dividing the
ﬁnal products by the intermediates.
Analysis ofphysical interaction of RNase H2 withPCNA
by gelfiltration column chromatography
Gel ﬁltrations of RNase H2, PCNA and their complex
were performed at 48C using a column (20 900mm)
packed with Sephacryl S-200 (GE Healthcare). The
column was equilibrated with 40mM Tris–HCl pH 7.5
containing 1mM EDTA and 150mM NaCl. To constitute
the complex between RNase H2 and PCNA, 12 nmol of
RNase H2 and 50 nmol of PCNA were incubated for
15min at 48C. Then, the protein mixture was chromato-
graphed at 0.6ml/min ﬂow-rate. Fractions were collected
and analyzed on 10–20% gradient SDS–PAGE (Bio-Rad)
and stained with CBB.
Pull-down assay
The plasmid, pET17b-hPCNA, was constructed by sub-
cloning the NdeI/BamHI fragment containing human
PCNA gene from pAVR38 to the NdeI/BamHI site of
pET17b. For production of untagged human PCNA,
E. coli MIC1066 was transformed with pET17b-hPCNA
and grown overnight in MagicMedia
TM (Invitrogen) at
328C. Escherichia coli MIC1066 harboring pET-
hH2BC2, pET-hH2ABC and pET-hH2ABC AGS-related
derivatives were grown and induced as described above.
For E. coli cell lysates 2ml of MagicMedia
TM overnight
cultures were harvested and resuspended in 500mlo f
40mM Tris–HCl pH 7.5 containing 25% sucrose, 10mg/
ml lysozyme, 10mM EDTA and 1% Triton X-100 and
incubated for 30min on ice. Next, 15ml of 0.5M MgCl2,
1ml of 50mg/ml RNase A and 10ml of 10 U/ml DNase I
were added, mixed and incubated on ice for 10min. The
samples were centrifuged and the supernatant was taken
as the crude lysate. To facilitate the protein–protein inter-
action, the lysates containing RNase H2 and PCNA were
incubated at 48C for 1h with rotation. His-tagged RNase
H2 was pulled down by 100ml of Talon superﬂow metal
aﬃnity resin (Clontech). The resin was washed with
40mM Tris–HCl pH 7.5 containing 500mM NaCl and
5mM imidazole. Proteins were eluted with 40mM Tris–
HCl pH 7.5 containing 500mM NaCl and 500mM imida-
zole. The samples were analyzed by SDS–PAGE stained
with CBB and western blotting with anti-PCNA antibody
(Sigma).
RESULTS
Purification of human RNase H2 fromHeLa cell line
To facilitate puriﬁcation of human RNase H2 from
human cells, we constructed a HeLa cell line that stably
expresses N-terminally FLAG- and HA-tagged human
RNASEH2A (HeLa RNASEH2A cell) using an
MMLV-based retrovirus vector. Expression of FLAG-
HA-tagged RNASEH2A in the HeLa RNASEH2A cell
line was conﬁrmed by western blotting with anti-FLAG
antibody (data not shown).
Cell extracts were prepared from HeLa RNASEH2A
cells and untransduced HeLa cells, and the RNase H
activity of these samples was analyzed using 50-end
labeled
32P-RNA20/DNA20 hybrid,
32P-DNA12-RNA1-
DNA27/DNA40 hybrid and uniformly labeled
32P-poly-rA/
poly-dT as substrates (Figure 1). The substrates with a
single ribonucleotide have been reported to be cleaved by
RNase H2 but not by RNase H1 (26). Pattern and eﬃ-
ciency of cleavage were very similar for extracts from
HeLa RNASEH2A cells and untransduced HeLa cells
(Figure 1), suggesting that overexpression of only the
RNASEH2A subunit does not aﬀect total RNase H activ-
ity in the HeLa cell line. Puriﬁcation of human RNase H2
from the HeLa RNASEH2A cells was carried out with
anti-FLAG antibody-conjugated resin, and the RNase H
activity of puriﬁed fractions from HeLa RNASEH2A cells
and mock cells was analyzed (Figure 1). The FLAG-tag
puriﬁed fraction from HeLa RNASEH2A cells showed
signiﬁcantly higher RNase H2 activity than the mock-
cell-puriﬁed fraction, which showed only negligible hydro-
lysis of the
32P-poly-rA/poly-dT substrate (Figure 1C).
This one-step puriﬁcation recovered 20–40% of total cell
extract RNase H activity.
Total cell extracts and the FLAG-puriﬁed fraction
from HeLa RNASEH2A cells produced very similar
cleavage patterns (Figure 1A) of a 20-bp RNA/DNA
hybrid, for which RNase H1 and RNase H2 showed dif-
ferent cleavage preferences (27), suggesting that RNase
H2 provides most of the RNase H activity detected in
this assay. Depletion of RNase H1, the other cellular
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Figure 1. RNase H activity in cell extracts and FLAG-tag puriﬁed fractions from RNASEH2A expressing and untransduced HeLa cell lines.
The 50-end
32P-labeled 20-bp RNA/DNA hybrid (A) and DNA12–RNA1–DNA27/DNA40 hybrid (B) were cleaved with increasing amounts of the
total cell extracts and FLAG-tag puriﬁed fractions from RNASEH2A expressing cells (H2A) and untransduced cells (mock) at 378C for 15min. The
500ml cell extracts from 10
7 cells yielded 200ml of FLAG-puriﬁed samples as described in Materials and methods section. Ten picomoles of substrates
were treated with 1ml of the samples in 10ml of reaction mixtures. Protein samples were diluted in Dilution Buﬀer. Lanes 1, 4, 7 and 10 contained
0.002ml equivalents of the undiluted sample, lanes 2, 5, 8 and 11 contained 0.02ml equivalents and lanes 3, 6, 9 and 12 contained 0.2ml equivalents.
After digestion the reactions were electrophoresed in a 20% TBE-urea PAGE and the gel analyzed on a phosphoimager. Note (B) the mobilities of
the DNA12 product of DNA12–RNA1–DNA27/DNA40 migrates faster than the RNA size markers due to inherent diﬀerences in migration in the gels
between RNA and DNA. In (A), major cleavage sites of 20-bp RNA/DNA hybrid with RNase H1 and RNase H2 are indicated with blue and red
arrows, respectively. The main cleavage product of RNase H2 is indicated by a thick red arrow. Molecular size markers are indicated as M (products
of digestion of
32P-labeled 20-mer RNA by Phosphodiesterase I) (measuring the sites of cleavage from the 50- label of the 20-mer RNA) and D
(products of digestion of
32P uniformly labeled poly-rA/poly-dT by mouse RNase H1) (measuring the sizes of products that have uniform sequences).
(C) Uniformly
32P-labeled poly-rA/poly-dT (1mM) was cleaved with increasing amount of the total cell extracts and FLAG-tag puriﬁed fractions.
Amounts of samples in lanes 1–12 are equivalent to those of (A). The ratios of cleavage products were determined by measuring the acid-soluble
radioactivity. (D) SDS–PAGE of the puriﬁed RNase H2 from HeLa RNASEH2A cells with the two-step aﬃnity immunopuriﬁcation. HeLa
RNASEH2A cells were extracted and subjected to anti-FLAG and anti-HA two-step puriﬁcation. The puriﬁed sample was analyzed by SDS–
PAGE stained with silver staining. The fragment indicated with A1, A2 and A3 were identiﬁed by mass spectrometry, as described in text.
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modest decrease of cleavage products at 5u–6g and 7a–8a
(Figure 1A, blue arrows), known preferred sites of RNase
H1 (27). The gel renaturation assay conﬁrmed that RNase
H1 activity was depleted in the FLAG-tag puriﬁed frac-
tions (Supplementary Figure S1). These results demon-
strate that functional RNase H2 complex was puriﬁed
from HeLa cells by the FLAG-tag puriﬁcation.
To identify proteins interacting with RNASEH2A, two
step FLAG- and HA-epitopes immunopuriﬁcation was
conducted from  1l culture (19). Proteins that co-puriﬁed
with RNASEH2A were visualized by silver staining after
SDS–PAGE (Figure 1D). The major proteins (indicated
by A1, A2 and A3 in Figure 1D) were identiﬁed by mass
spectrometry. The identiﬁed proteins were heat-shock
70-kDa protein in A1, RNASEH2A and RNASEH2B
(FLJ11712) in A2 and RNASEH2C (AYP1) in A3
(Supplementary Table S2). This result indicates that
human RNase H2 forms a stable heterotrimer as does
yeast RNase H2 (2). The heat-shock 70-kDa protein, an
abundant protein in the HeLa cells, may or may not spe-
ciﬁcally associate with the RNase H2 complex, but it is
neither present in stoichiometric amounts nor required for
activity (see below). Crow et al. (3) identiﬁed the same
three proteins as components of the RNase H2 complex
and showed that mutations in the genes encoding any of
the three subunits can cause AGS, a human neurological
disorder.
Expression ofthe three subunits in E. coli complements an
rnhA-nulldefect
To demonstrate that the three RNase H2 subunits can
form an active enzyme in E. coli, we cloned all possible
combinations of the RNase H2 genes into plasmids under
the control of the T7 promoter and transformed E. coli
MIC1066, a strain that is temperature-sensitive for growth
due to an rnhA-null mutation in combination with a
recB(ts) mutation. Without induction, transcription from
the T7 promoter is often suﬃcient to supply enough
RNase H activity for cells to grow at the restrictive tem-
perature (20). Escherichia coli MIC1066 cells were trans-
formed with the plasmids and streaked on LB-ampicillin
plates. The plates were incubated at 32 and 428C. Only the
MIC1066 transformant harboring pET-hH2ABC could
grow at 428C, suggesting that functional human RNase
H2 is reconstituted in E. coli only when the three subunits
are coexpressed (data not shown).
Expression andpurification of human
RNase H2 from E. coli
To check the properties of the recombinant human RNase
H2, we expressed and puriﬁed the three subunits of the
complex using E. coli MIC1066 transformed with pET-
hH2ABC. In this expression system, all three subunits
are N-terminally His-tagged. The expression level of
RNASEH2A was estimated to be 5- to 10-fold higher
than those of RNASEH2B and RNASEH2C subunits
(Figure 2A). However, the three subunits were present in
the soluble fraction in a roughly 1:1:1 ratio, with most of
the excess RNASEH2A present in the insoluble fraction
(data not shown), indicating that the A subunit is stable
only as part of the trimeric complex. Coexpression of
RNASEH2B and RNASEH2C subunits also yielded solu-
ble forms of both proteins. In this case, production level of
the RNASEH2C subunit was roughly 10-fold higher
than that of RNASEH2B subunit (Figure 2A). These sub-
units were present in the soluble fraction in roughly a 1:1
ratio, and the excess of RNASEH2C accumulated in the
insoluble fraction (data not shown), suggesting that the
two proteins may form a complex that confers stability
to the two subunits. Other combinations of expression
resulted in accumulation of insoluble proteins (data not
shown).
Following coexpression of RNASEH2A/B/C or
RNASEH2B/C, two-step column chromatography was
used to purify the soluble proteins, and the puriﬁed sam-
ples were analyzed by SDS–PAGE (Figure 2A). After gel-
ﬁltration column chromatography, only single peaks were
obtained, showing that the three subunits of human RNase
H2 can form A/B/C and B/C complexes in E. coli. The
elution positions of human A/B/C and B/C complexes in
the gel ﬁltration column chromatography corresponded to
a subunit composition of 1:1:1 (for A/B/C complex)
and 1:1 (for B/C complex). For Sc-RNase H2A/B/C and
B/C complexes were also puriﬁed with subunit composi-
tion of 1:1:1 and 1:1, respectively (28).
Enzymatic characteristics of RNase H2 purified
fromHeLa cells and E. coli
We compared the properties of the human RNase H2
puriﬁed from HeLa cells with those of the recombinant
enzyme puriﬁed from E. coli by checking the enzymatic
activity dependence on pH, salt concentration and metal
ion concentration of both enzymes using as a substrate
poly-rA/poly-dT with uniformly
32P-labeled poly-rA
(Figure 2C–E). In all the conditions tested the enzymatic
properties were equivalent between human RNase H2
puriﬁed from HeLa cells and the recombinant protein
puriﬁed from E. coli.
The optimum pH for human RNase H2 activity was
8.2–8.8 and the activity was greatly decreased above the
optimum pH (Figure 2C). The reported pH-dependence
of Sc-RNase H2 activity is similar to that of human
RNase H2, while E. coli RNase HII was shown to increase
its activity as the pH increase from pH 7.0 to 9.8 (29).
NaCl was used to examine the eﬀects of salt on RNase
H2 activity. Human RNase H2 exhibited the highest activ-
ity in the presence of 50mM NaCl (Figure 2D), like
Sc-RNase H2 (28) and E. coli RNase HII (29). The depen-
dence of human RNase H2 activity on the metal ion
concentration was analyzed in the presence of various
concentrations of MgCl2 and MnSO4 (Figure 2E).
Human RNase H2 exhibited the highest activity in the
presence 5–10mM MgCl2 and 20–30% of the maximal
activity in the presence of 0.1–1.0mM MnSO4.I t
has been reported that Mn
2+-dependent activity of
E. coli RNase HII is over 10-fold higher than that of
Mg
2+-dependent activity for the cleavage of either M13
RNA/DNA hybrid (29) or 12-bp RNA/DNA hybrid (30),
while for the cleavage of 12-bp RNA–DNA/DNA
Nucleic Acids Research,2009, Vol. 37,No. 1 101Okazaki fragment model substrate, E. coli RNase HII
shows 10-fold higher activity in the presence of MgCl2
than MnCl2. On the other hand, Sc-RNase H2 exhibited
roughly 2-fold higher activity in the presence of MgCl2
than MnCl2 for the cleavage of DNA15–RNA1–DNA13/
DNA29 hybrid (28). Enzymatic activity of human RNase
H2 was greatly attenuated as the concentration of metal
ions exceeds the optimum concentrations as reported for
E. coli and Sc-RNase HII/2 (28,30). These biochemical
properties are consistent with those previously described
(26,31).
Cleavage pattern of 20-bp RNA/DNA hybrid was also
equivalent between human RNase H2 puriﬁed from
HeLa cells and the recombinant protein puriﬁed from
E. coli (Figure 2B). The major cleavage site, indicated by
the thicker red arrow in Figures 1A and 2B, was between
16c and 17g, 1nt diﬀerent than that reported by Pileur
et al. (27). This discrepancy most likely results from
the diﬀerent migration of size markers with 30-phosphate
by Pileur et al. and our markers, which have 50-phosphate
moieties as do the products generated by RNases H2.
Cleavage of short hybrid substrates withhuman RNase H2
and E. coli RNase HII
Since the HeLa cell-derived RNase H2 and that expressed
in E. coli have such similar biochemical properties, all
subsequent analyses of human RNase H2 were performed
using the recombinant protein puriﬁed from E. coli.T o
analyze the eﬀect of RNASEH2B and RNASEH2C on the
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Figure 2. Comparison of enzymatic characteristics of human RNase H2 puriﬁed from HeLa cells and E. coli.( A) SDS–PAGE of human RNase H2
expressed in E. coli. Whole-cell extracts of overnight culture of E. coli MIC1066 transformed with pET15b (lane 1), pET-hH2ABC (lane 2) and pET-
hH2BC2 (lane 3), and puriﬁed human RNase H2A/B/C complex (lane 4) and B/C complex (lane 5) were analyzed by 10–20% gradient SDS–PAGE
(Bio-Rad) and the gel was stained with CBB. The molecular weight marker is Rainbow Marker from Amersham Bioscience. The proteins corre-
sponding to RNASEH2A, RNASEH2B and RNASEH2C are indicated as A, B and C, respectively. (B) Cleavage of 20-bp substrate with human
RNase H2 puriﬁed from HeLa cells and E. coli. The 50-end
32P-labeled 20-bp RNA/DNA hybrid (10 pmol) was hydrolyzed with human RNase H2
puriﬁed from HeLa cells (as in lane 8 of Figure 1A) and E. coli (12 fmol) at 378C for the time (min) indicated above each lane in 10ml reaction
mixtures. Molecular size marker is indicated with M (products of digestion of
32P-labeled 20-mer RNA by Phosphodiesterase I). The digested
products were analyzed by 20% TBE-urea PAGE. Prominent cleavage sites were indicated with red arrows. The thick red arrow indicates the main
cleavage site. Dependence of pH (C), salt concentration (D) and Mg
2+ and Mn
2+ ions concentration (E) of human RNase H2 puriﬁed from HeLa
cells (ﬁlled) and E. coli (open) were analyzed using uniformly
32P-labeled poly-rA/poly-dT substrate. MgCl2 and MnSO4 concentrations were
indicated by circle and triangle in (E), respectively.
102 Nucleic Acids Research, 2009, Vol. 37, No. 1cleavage speciﬁcity of RNase H2, we compared the activ-
ity of the heterotrimeric human RNase H2 with that of the
monomeric RNase HII from E. coli using two diﬀerent
substrates. The 50-end labeled
32P-DNA12–RNA1–
DNA27/DNA40 hybrid and 50-end labeled
32P-RNA20/
DNA20 hybrid were digested with human RNase H2 and
E. coli RNase HII in the presence of optimum concentra-
tion of MgCl2 (Figure 3). Each enzyme cleaved the
RNA20/DNA20 hybrid at multiple sites between 3u and
18a, but the major cleavage sites were diﬀerent for each
enzyme (for example, compare lanes 15 and 23 in
Figure 3B). The cleavage pattern of human RNase H2
on
32P-RNA20/DNA20 hybrid was very similar to that of
Sc-RNase H2 (2).
32P-DNA12–RNA1–DNA27/DNA40
hybrid was cleaved by human RNase H2 and E. coli
RNase HII at the same position (Figure 3A), although
E. coli RNase HII cleaved this substrate more eﬃciently
than human RNase H2. Human RNase H2 cleaved both
substrates with similar eﬃciencies, as seen before with the
enzyme puriﬁed from HeLa cells (Figure 1A and B).
However, the E. coli RNase HII cleaved more eﬃciently
the single-ribonucleotide embedded substrate, in accor-
dance with a recent report describing a preference of the
E. coli enzyme for cleaving RNAs when part of a junction
substrate (30).
HumanRNase H2cleaves poly-rA/poly-dT inaprocessive
manner
To determine whether the RNASEH2B and RNASEH2C
subunits of human RNase H2 contribute to substrate
interactions, we examined the mode of cleavage of
human RNase H2 and E. coli RNase HII on uniformly
labeled
32P-poly-rA/poly-dT (Figure 4). Short oligonu-
cleotides with very few intermediate-sized products
appeared throughout the reaction using human RNase
H2. In contrast, E. coli RNase HII initially generated a
broad size range of cleavage products that were eventually
converted to short oligonucleotides. Relative quantities of
small and intermediate products were determined for sam-
ples in which <15% of the initial substrate had been
degraded. Processivity, deﬁned as the ratio of the amounts
of small- to intermediate-sized products as described pre-
viously (25), showed a more than a 10-fold diﬀerence
between the human RNase H2 and E. coli RNase HII
(Figures 4 and 5).
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Figure 3. Comparison of cleavage pattern of short substrates with human RNase H2 and E. coli RNase HII. The 50-end
32P-labeled DNA12–RNA1–
DNA27/DNA40 hybrid (A) and 20-bp RNA/DNA hybrid (B) were cleaved with human RNase H2 and E. coli RNase HII at 378C for 15min. The
reaction volume was 10ml and the substrate concentration was 1mM. Amounts of proteins for human RNase H2 were 1.2 fmol (lanes 2 and 14), 12
fmol (lanes 3 and 15), 120 fmol (lanes 4 and 16), 1.2 pmol (lanes 5 and 17), 12 pmol (lanes 6 and 18). The amounts of protein for E. coli RNase HII
were 7.6 fmol (lanes 8 and 20), 76 fmol (lanes 9 and 21), 760 fmol (lanes 10 and 22), 7.6 pmol (lanes 11 and 23), 76 pmol (lanes 12 and 24). Lanes 1,
7, 13 and 19 contained no enzymes. The digested products were analyzed by 20% TBE-urea PAGE. Molecular size markers are indicated as M
(products of digestion of
32P-labeled 20-mer RNA by Phosphodiesterase I) and D (products of digestion of
32P-labeled poly-rA/poly-dT by mouse
RNase H1).
Nucleic Acids Research,2009, Vol. 37,No. 1 103We previously reported that eukaryotic RNase H1
cleaves the poly-rA/poly-dT substrate in a processive
manner that requires the N-terminal hybrid binding
domain (HBD) and that E. coli RNase HI, which does
not possess an HBD, cleaves the substrate in a distributive
manner (25). We compared human RNase H2 and mouse
RNase H1 and found that processivity of these proteins
was very similar but RNase H1 of mouse had a 4-fold
higher speciﬁc activity (data not shown).
Effectof AGS-related mutation on activity andprocessivity
Mutations in RNASEH2B and RNASEH2C have
been described to cause AGS (3,4), although their
eﬀecton RNaseH activity is not known. Here, we analyzed
the enzymatic activity of ﬁve mutations, three in
RNASEH2B: Lys162 to Thr (RNase H2b-K162T),
Ala177 to Thr (RNase H2B-A177T), Val185 to Gly
(RNase H2b-G185V) and two in RNASEH2C: Arg69 to
Trp (RNase H2C-R69W) and Lys143 to Ile (RNase H2C-
K143I). We also re-examined the activity of a previously
described mutation in RNASEH2A: Gly37 to Ser (RNase
H2A-G37S). We produced the AGS-related mutant pro-
teins in E. coli and puriﬁed them as described for wild-
type protein. Production level and solubility of the
AGS mutant proteins were similar to those of wild-type
protein (data not shown). Speciﬁc activity and processivity
of the mutant proteins relative to the activity and proces-
sivity of the wild-type enzyme are shown in Figure 5.
RNase H2A-G37S showed greatly reduced activity as
reported previously (3). Processivity was also reduced in
the G37S mutation. RNase H2C-R69W retained 30–40%
of RNase H activity, while the processivity of the mutant
protein was not signiﬁcantly diﬀerent from that of wild-
type protein. All other mutant RNases H2 have activity
and processivity values similar to wild type.
Conservation of PCNA-interacting motif at theC-terminus
of RNASEH2B
We found that a putative PCNA interacting protein-box
sequence (PIP-box) is present at the C-terminus of human
RNASEH2B at residues 294–301 (Figures 5 and 6). The
PIP-box (32) is one of the few regions of RNASEH2B that
is highly conserved among species (3). Many PCNA inter-
acting proteins contain the typical PIP-box (16),
Qxxmxx (m, aliphatic hydrophobic residues; , aro-
matic residues; x, any residue). Eukaryotic RNASEH2B
conserves the three hydrophobic residues motif, mxx,
while the ﬁrst Gln is not conserved in the putative PIP-box
of RNASEH2B.
RNase H2physically interacts withPCNA invitro
To determine whether the putative PIP-box present
in RNASEH2B confers binding to PCNA, we anal-
yzed the physical interaction between RNase H2 and
PCNA by gel ﬁltration column chromatography and by
co-precipitation using aﬃnity tags. PCNA and RNase H2
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Figure 4. Cleavage of poly-rA/poly-dT substrate with human RNase H2 and E. coli RNase HII. (A) The uniformly
32P-labeled poly-rA/poly-dT
(1mM) was digested with human RNase H2 (0.25 fmol) and E. coli RNase HII (76 fmol) at 378C for the times indicated for each lane. Samples were
analyzed by 20% TBE-urea PAGE as described in Materials and methods section. (B) Graphical representations of degradation of the substrate at
the time points 0 (black), 2 (red), 6 (purple) and 15min (blue) are shown. (C) Processivity values are from at least three independent experiments.
104 Nucleic Acids Research, 2009, Vol. 37, No. 1were puriﬁed from E. coli and applied to a gel ﬁltration
column. PCNA and RNase H2 when applied separately
eluted in fractions 39–45 and 37–43, respectively
(Figure 7A). A mixture of 12 nmol of RNase H2 complex
and 50 nmol of the homotrimeric PCNA was analyzed on
the same gel ﬁltration column, and we found that
the elution of RNase H2 shifted to fractions 31–37, indi-
cating that RNase H2 formed a complex with PCNA
(Figure 7A). Elution of PCNA occurred over a broad
range, some of which was coincident with the shifted
RNase H2, with the excess PCNA eluting later.
To demonstrate that the putative PIP-box is responsible
for the RNase H2 interaction with PCNA, we constructed
RNASEH2B mutations either by changing the two con-
served Phe to Ala (RNase H2FA) or by deleting the
C-terminal 18 amino acids that include the putative
PIP-box (RNase H2PIP) (Figures 6 and 7B), and the
physical interaction of PCNA with wild-type human
RNase H2 and the PIP-box mutants was analyzed by
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Figure 5. Relative speciﬁc activity and processivity. (A) Schematic representation of the recombinant human RNase H2 three subunits. Numbers
represent the position of the amino acid residues relative to the N-terminal methionine after the pET15b-derived His-tag. AGS-related mutations
examined in this study are shown above each subunit. Conserved catalytic residues (D34, E35, D141 and D169) are shown below RNASEH2A. The
region shown in black (K294 to F301) in RNASEH2B represents the PIP-box. (B, C) A bar graph of relative speciﬁc activity and processivity: (B)
Relative speciﬁc activity (red) and processivity (green) of human RNase H2 wild type and AGS-related mutants and E. coli RNase HII (EcHII) was
analyzed using uniformly
32P-labeled poly-rA/poly-dT as a substrate. (C) Relative speciﬁc activity of human RNase H2 wild-type and AGS-related
mutants was analyzed by
32P-labeled DNA12–RNA1–DNA27/DNA40 hybrid. The relative values were normalized to wild type RNase H2 (100%).
The error bars represent the standard deviation of at least three independent measurements.
Hs:     DKSGMKSIDTFFGVKNKKKIGKV
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Figure 6. PCNA binding motif at the C-terminus of eukaryotic
RNASEH2B. Amino acid sequences of C-terminus of archaeal
RNase HII and eukaryotic RNASEH2B and the consensus PCNA
interacting protein box (PIP-box) are aligned. m is aliphatic hydropho-
bic,  is aromatic and x is any residue (32). Conserved residues are in
boldface. Hs, Homo sapiens; Mm, Mus musculus; Rn, Rattus norvegicus;
Xt, Xenopus tropicalis; Gg, Gallus gallus; Tn, Tetraodon nigroviridis;
Dm, Drosophila melanogaster; Ce, Caenorhabditis elegans; Am, Apis
mellifera; Dd, Dictyostelium discoideum; Os, Oryza sativa; Spo,
Schizosaccharomyces pombe; Sce, Saccharomyces cerevisiae.
Nucleic Acids Research,2009, Vol. 37,No. 1 105metal aﬃnity pulldown assays (Figure 7B). Escherichia
coli harboring pET15b was used as a negative control.
PCNA was pulled down together with RNase H2A/B/C
trimeric complex and B/C dimeric complex. Alterations in
the PIP-box resulted in a great decrease on the amount of
PCNA interacting with RNase H2. These results suggest
that the PIP-box is required for physical interaction with
PCNA.
Eﬀects of the six AGS-related mutations on the physical
interaction with PCNA were also examined (Figure 7C).
As expected, since the mutations did not map to the
PIP-box, the amounts of PCNA pulled down with these
AGS-related mutants were equivalent to that of wild-type
protein.
Effect of PCNA on RNase H2 activity
To determine whether RNase H2 activity is aﬀected
by interacting with PCNA, RNase H assays were per-
formed with a very wide range in the ratio of RNase
H2/PCNA concentrations. The reactions contained 150
fmol of 50-end
32P-labeled DNA12–RNA1–DNA27/
DNA40 hybrid, DNA39–RNA1–DNA40/DNA80 hybrid
and RNA20/DNA20 hybrid. RNase H2 amounts were 3
fmol [Figure 8 (i) and (ii)] and 1.2 fmol [Figure 8 (iii)].
PCNA levels ranged from 0.3 to 30 pmol some 2–200
times that of the substrates. Representative data are
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Figure 7. Physical interaction of RNase H2 with PCNA. (A) Physical
interaction between RNase H2 and PCNA was analyzed using gel
ﬁltration column chromatography. Mixture of RNase H2 and PCNA
(top), PCNA alone (middle) and RNase H2 alone (bottom) were ana-
lyzed on the gel ﬁltration column. The indicated fractions were sub-
jected to 10–20% gradient SDS–PAGE and the proteins were visualized
by CBB. A representative result is shown in this ﬁgure. A, B, C, and
PCNA mark the migration of RNASEH2A, RNASEH2B,
RNASEH2C and PCNA, respectively. (B) PCNA interacts with C-
terminal tail of RNASEH2B: Bacterial lysate containing untagged
PCNA was incubated with bacterial lysates containing His-tagged
wild-type RNase H2A/B/C complex, B/C complex, mutant A/B/C
complex with two F to A mutations in PIP-box (RNase H2FA) and
mutant A/B/C complex with PIP-box deleted (RNase H2PIP). Pulled-
down samples were analyzed by SDS–PAGE with CBB stain and wes-
tern blotting with anti-PCNA antibody. (C) AGS-related mutations do
not aﬀect physical interaction between RNase H2 and PCNA: Bacterial
lysate containing untagged PCNA was incubated with bacterial lysates
containing His-tagged wild-type RNase H2 and mutant RNase H2 with
AGS-related mutations. Pulled-down samples were analyzed by western
blotting with anti-PCNA antibody.
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Figure 8. Cleavage of oligomeric substrates with RNase H2 in the
presence of PCNA. The 50-end
32P-labeled DNA12–RNA1–DNA27/
DNA40 hybrid (i), DNA39–RNA1–DNA40/DNA80 hybrid (ii) and
20-bp RNA/DNA hybrid (ii) were cleaved with human RNase H2
(3 fmol for DNA12–RNA1–DNA27/DNA40 and DNA39–RNA1–
DNA40/DNA80 hybrids, 1.2 fmol for 20-bp RNA/DNA hybird) at
378C for 15min. The reaction volume was 10ml. Substrates amounts
were 150 fmol. PCNA quantities were 300 fmol (lanes 4, 12 and20), 1
pmol (lanes 5, 13 and 21), 3 pmol (lanes 6, 14 and 22), 10 pmol (lanes
7, 15 and 23), 30 pmol (lanes 2, 8, 10, 15, 18 and 24). Lanes 1, 9 and 17
contained no enzyme. Reactions were analyzed by 20% TBE-urea
PAGE.
106 Nucleic Acids Research, 2009, Vol. 37, No. 1shown in Figure 8. Enzymatic activity and processivity of
human RNase H2 were unaﬀected under any of the con-
ditions tested. Similarly, the activity of yeast RNase H2
also was unaﬀected by the presence of PCNA (data not
shown).
DISCUSSION
Human and S. cerevisiae RNASEH2A have strong
sequence similarity to prokaryotic RNases HII, which is
functionally active as a single polypeptide. However,
both eukaryotic RNases H2 require two additional sub-
units to constitute an active enzyme. In this report, we
describe a role for the RNASEH2B and RNASEH2C sub-
units in providing a structural support for the catalytic
RNASEH2A subunit to become active, and hydrolyze
its RNA/DNA hybrid substrate in a processive manner.
The RNASEH2B and RNASEH2C subunits also act as a
platform for interactions with other proteins, such as
PCNA, which in this work was found to bind human
RNase H2 through the PIP-box located in the
RNASEH2B subunit.
Role ofRNASEH2B andRNASEH2C subunits
Tagged-RNASEH2A in stably transfected HeLa cells per-
mitted puriﬁcation of the three-subunit complex in a 1:1:1
ratio, with little or no excess RNASEH2A suggesting that
any protein not interacting with the RNASEH2B and
RNASEH2C proteins did not survive as a separate pro-
tein. Unless RNASEH2B and RNASEH2C were present
during expression in E. coli, RNASEH2A was found only
in the insoluble fraction. Thus, it seems that RNASEH2B
and RNASEH2C provide a means to generate an active
enzyme by forming a scaﬀold on which the catalytic
RNASEH2A can assume its appropriate conﬁguration.
Human RNASEH2B and RNASEH2C subunits share
little amino acid sequence similarity with their S. cerevisiae
homologues (3,28), however, both human and Sc-RNase
H2 B and C subunits can be puriﬁed as soluble dimers
after expression in E. coli [Figure 2A and (28)], suggesting
that B/C complex formation may be important in both
organisms. Such B/C complexes could serve as a platform
that incorporates additional proteins to support functions
other than RNase H2. Direct protein–protein assessments
in S. cerevisiae showed that RNASEH2A interacts exclu-
sively with RNASEH2B and RNASEH2C. In contrast,
RNASEH2B has been reported to interact with BUD32
and INP52 (33) in aﬃnity capture-MS studies. This
method also uncovered the binding of RNASEH2C to
KSS1 and TOP2 (33). In our assays we found that
RNASEH2B interacts with PCNA when is part of a func-
tional complex containing A/B/C subunits or as part of
the inactive B/C complex.
In our human RNase H2A/B/C coexpression system in
E. coli, only the A/B/C complex was present in a soluble
form, while in the case of Sc-RNase H2, coexpression of
the three subunits in E. coli resulted in accumulation of
both A/B/C and B/C complexes (28). Coexpression of the
human proteins produced a large ( 10-fold) excess of the
RNASEH2A subunit (Figure 2), while in the Sc-RNase
H2 expression system the amount of RNASEHA subunit
was much lower than that of RNASEH2B and
RNASEH2C. These results suggest that the ratio of
expression of the three subunits may be regulated to pro-
duce A/B/C or B/C complexes. The mRNAs encoding the
three subunits of Sc-RNase H2 are most abundant during
the S and G2/M phases of the cell cycle (34,35).
Coincident changes in S. cerevisiae mRNAs could indicate
that all the proteins that interact with B/C complex,
including the A subunit, are involved in processes that
occur in S and G2/M phases. The data of mRNAs encod-
ing the human RNase H2 subunits are not clearly consis-
tent but there does appear to be some change in amounts
during the cell cycle (36).
Physicalinteraction between RNase HII/2 and PCNA
isevolutionally conserved
One important contribution of RNASEH2B is to provide
a PIP-box for interaction with PCNA (Figure 7). PCNA
functions as a platform to recruit interacting proteins at
the ‘right time and place’ during DNA replication and
repair (17). In some cases, PCNA has been shown to sti-
mulate the enzymatic activity of the interacting protein
(17) most likely by facilitating substrate binding. In our
assays, using linear substrates of various lengths, addition
of PCNA showed no eﬀect on the enzymatic activity of
RNase H2 (Figure 8), although PCNA could be required
for loading RNase H2 into certain substrates, such as
circular nucleic acids, or RNA/DNA hybrids with blocked
ends, substrates similar to the ones found in vivo.
Recently, it was shown that Pab-RNase HII interacts
with PCNA through its C-terminal tail, which contains a
PIP-box (18). We searched a NCBI database and found
that many archaeal RNases HII possess putative PIP-
boxes at their C-termini (Supplementary Table S3). It
was reported that the enzymatic activity of Pab-RNase
HII was inhibited by 80% in assays using equimolar
amounts of RNase HII, a DNA7-RNA1-DNA7/DNA15
hybrid substrate and PCNA (18), a result quite diﬀerent
from our observation with the human enzyme. The
archaeal enzyme has the PIP-box directly attached to the
single protein comprising the enzyme. Perhaps the more
complex human RNase H2 has adapted a diﬀerent
approach to interact with PCNA that does not interfere
with its activity. These results suggest that physical inter-
action between RNase HII/2 and PCNA is conserved
from archaea to eukaryotes, although the eﬀect on enzy-
matic activity needs further studies.
During lagging strand synthesis, PCNA brings together
and coordinates the proteins involved in DNA elongation
and maturation, such as DNA polymerase d(Pol d), the
ﬂap cleavage endonuclease, FEN1 and the nick closure
ligase, Lig1 (32). The nick translation activity of Pol d in
cooperation with FEN1 and DNA2 nucleases has been
shown to be the main pathway for Okazaki fragment
maturation (32). However, several yeast genetic studies
have indicated that deletion of RNase H2 in combination
with defects in DNA2 (37) or RAD27 (FEN1) (12,13) has
synthetic lethal or sickness phenotypes, suggesting func-
tional overlapping of RNase H2 with these Okazaki
Nucleic Acids Research,2009, Vol. 37,No. 1 107fragment maturation enzymes (32). The fact that RNase
H2 binds to PCNA also suggests that RNase H2 is
involved in replication and repair. Analysis on the
in vivo interaction with PCNA will give new insights into
the physiological function of RNase H2.
Substraterecognition by RNase H2
Human RNase H2 acts in a processive manner for which
RNASEH2B and RNASEH2C may be important since
the single polypeptide RNase HII enzyme from E. coli
acts in a distributive manner (Figure 4). RNase H1/I,
the other class of RNases H follows the same pattern:
they are processive enzymes in eukaryotic cells while
their prokaryotic counterparts are not. This strongly sug-
gests the presence of long, complex hybrids in eukaryotes
that require processive cleavage.
Human RNase H2 does not exhibit any signiﬁcant pre-
ference for cleaving the single ribonucleotide-embedded
substrate over a typical RNA/DNA hybrid (Figure 4).
However, several prokaryotic RNases HII prefer hydro-
lyzing the embedded ribonucleotide hybrid, and in a
recent report, it was described that the RNase HII homo-
logue from a highly thermophilic bacterium, Thermus
thermophilus, cleaved the embedded ribonucleotide
hybrid and the ribonucleotide adjacent to the DNA in a
model Okazaki fragment hybrid, but it did not hydrolyzed
the usual RNA/DNA substrate (30). Moreover, bacterial
RNase HIII, which is a type 2 RNase H and structurally
(38) very similar to archaeal (39,40) and bacterial RNases
HII (PDB:2etj), would not hydrolyze a single embedded
ribonucleotide DNA substrate (41).
The ability of human RNase H2 to act in a processive
manner and hydrolyze a variety of RNA/DNA hybrids
with similar eﬃciencies suggests that it may participate in
many cellular processes (e.g. as a surveillance mechanism
to ﬁnd and cleave single ribonucleotides in DNA, leading
to their removal by repair enzymes, or acting to remove
R-loops that may be generated during transcription).
Effectof AGS-related mutation
Mutations in the three subunits of RNase H2 and
TREX1, a ssDNA exonuclease, have been found as cau-
sative of AGS (3,5), suggesting that accumulation of DNA
and RNA by-products is a main factor that induces virus
infection-like phenotypes in AGS (3).
The earliest appearance and most severely aﬀected
AGS patients have mutations in the RNASEH2A
and RNASEH2C subunits (RNASEH2A G37S and
RNASEH2C R69W) whereas phenotypic presentation of
AGS in children with RNASEH2B mutations occurs sig-
niﬁcantly later (4). In addition, patients with RNASEH2B
mutations tend to live longer than those with mutations in
other genes.
Of all theAGS-related mutations examined in this study,
only the RNASEH2A G37S substitution exhibited a severe
decrease in the enzymatic activity of the complex, as pre-
viously reported (3). RNASEH2C R69W mutant enzyme
was about 35% as active as wild-type RNase H2, which
may account for the severity of AGS-phenotype in patients
with this mutation. However, the other mutant proteins,
RNase H2B-K162T, -A177T and -V185G and RNase
H2C-K143I had almost normal levels of RNase H activity
(Figure 5). A recent report (28) describes the eﬀect of
AGS-causing mutations on the activity of RNase H2
from S. cerevisiae and Thermococcus kodakaraensis.
While G37 is clearly conserved in these diﬀerent organ-
isms, and consequently mutations of this amino acid
have similar eﬀects, the great divergence of the B and C
subunits between human and S. cerevisiae make it diﬃcult
to assess the eﬀects of AGS-related mutation in the yeast
system (28). However, it is clear that RNase HII activity of
T. kodakaraensis is impaired when the conserved Gly is
changed to other amino acids with bulkier side chains,
presumably limiting access to the active site.
The failure to note diﬀerences in activity in our in vitro
studies does not preclude small defects in enzymatic activ-
ity that would induce the accumulation of unprocessed
hybrids over long periods of time. Perhaps the mutations
that give rise to later onset of AGS symptoms, such as
those found in the RNASEH2B, are not related to speciﬁc
activity per se but to stability or complex formation. If our
suggestion that the RNASEH2B/C heterodimer is the
platform on which the RNASEH2A subunit is properly
assembled, some of the mutations in the RNASEH2B or
RNASEH2C subunits may be defective in assembly/
stability.
The 13 missense mutations present in the RNASEH2B
gene are in exons 2–8 (4). Interestingly, no AGS-related
mutation has been found in exons 9–11. Thus, the PIP-box
of RNASEH2B is normal in all of the examined AGS-
related mutant proteins, and consequently they showed
normal PCNA interaction (Figure 7C). Interaction with
PCNA, which is required to participate in DNA replica-
tion and repair, may be essential for RNase H2 function
and therefore mutations in the PIP-box of RNASEH2B
may not be viable.
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